Business
CROSSJECT implements new manufacturing module to scale-up the ZENEO® Factory ‘s versatility and capacity in anticipation of full product pipeline deployment
Press release CROSSJECT implements new manufacturing module to scale-up the ZENEO® Factory ‘s versatility and capacity in anticipation of full product pipeline deployment CROSSJECT developed the ZENEO® Nest, a new module to improve batch aseptic filling of the proprietary glass drug container of the ZENEO® device, to be implemented by December 2025.Consistent with its ability to diversify its financing sources, CROSSJECT obtained a new equipment financing dedicated to the implementation of the Z
About this update from Crossject Sa
[{"type":"image","alt":"CROSSJECT","displaySize":"","headline":null,"caption":"CROSSJECT","className":"","disableSlideshowImg":false,"size":{"original":{"width":200,"height":87,"url":"https://media.zenfs.com/en/globenewswire.com/5049eda363ac301cbfd1577dab53d65a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/rK9m607pcnIrkhBB4D_IFA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTM2MDtoPTE1NztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/5049eda363ac301cbfd1577dab53d65a","width":200,"height":87}},"lazy":false},{"type":"text","content":"Press release","length":13,"tagName":"p"},{"type":"text","content":"CROSSJECT implements new manufacturing module to scale-up the ZENEO® Factory ‘s versatility and capacity in anticipation of full product pipeline deployment","length":156,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"CROSSJECT developed the ZENEO® Nest, a new module to improve batch aseptic filling of the proprietary glass drug container of the ZENEO® device, to be implemented by December 2025.","length":180,"tagName":"p"}]},{"val":[{"type":"text","content":"Consistent with its ability to diversify its financing sources, CROSSJECT obtained a new equipment financing dedicated to the implementation of the ZENEO® Nest.","length":160,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":340,"olType":false},{"type":"text","content":"Dijon, France 27 May 2025 (07h30 CET) -- CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ), the specialty pharma company in advanced phases of development and registration for ZEPIZURE®, an emergency injectable for the management of epilepsy crises, scales-up key steps in the ZENEO® Factory manufacturing process. The implementation of this innovation, planned for 2025, is a strategic step in anticipation of the broad deployment of ZEPIZURE® and of its other pipeline product candidates.","length":487,"tagName":"p"},{"type":"text","content":"CROSSJECT developed the ZENEO® Nest, a new module to facilitate an automated, high volume aseptic filling of the proprietary glass drug container inside the ZENEO® device. The ZENEO® Nest pre-assembles such containers for faster, batched filling, translating into higher volumes per day within the reserved room units of CROSSJECT’s CDMO partners. More importantly, the ZENEO® Nest was designed to be compatible with many filling set-ups or equipment lines in the CDMO industry....